worldwiki
개념 · Medical

Anti-aging Treatment

다른 이름: 안티에이징, 항노화 치료

발행 2026년 9월 14일갱신 2026년 11월 12일
이 사이트의 서버 로그에 기록된 요청이며, 크롤러 신원은 역DNS 또는 IP 대역으로 확인합니다.Meta64OpenAI42Google13Ahrefs6Apple2Parallel2Microsoft2Anthropic1Perplexity1첫 수집 2026년 9월 15일최근 요청OpenAI2026년 11월 12일OpenAI2026년 11월 11일OpenAI2026년 11월 10일OpenAI2026년 11월 9일 · 499OpenAI2026년 11월 9일OpenAI2026년 11월 8일OpenAI2026년 11월 8일OpenAI2026년 11월 7일OpenAI2026년 11월 6일OpenAI2026년 11월 5일OpenAI2026년 11월 4일OpenAI2026년 11월 4일
정정 요청
언어English아직 이 언어로 번역되지 않아 영문 원문을 표시합니다.
정의

Anti-aging treatments are medical or cosmetic interventions intended to reduce visible or functional signs of aging; evidence quality varies widely.

빠른 답변

What are anti-aging treatments and are cell-based ones proven?

Anti-aging treatments range from skin procedures and energy-based lifting to hormonal and cell-based approaches. Cell-based anti-aging treatments such as systemic injection of SVF or "stem cells" for wellness are investigational in most countries; the U.S. FDA has warned consumers about unapproved stem cell products. Ask for peer-reviewed evidence and regulatory status before any cell-based anti-aging treatment.

검증 2026년 9월 15일

핵심 사실

항목값출처
FDA-approved stem cell products (US)Only blood-forming stem cells (hematopoietic progenitor cells) from umbilical cord blood are FDA-approved in the US. They are approved only for blood-production disorders, not for anti-aging.기준 2024년 4월 9일[2]governmentConsumer Alert on Regenerative Medicine Products Including Stem Cells and ExosomesU.S. Food and Drug Administration
Exosome products (US)The FDA has approved no exosome products기준 2024년 4월 9일[2]governmentConsumer Alert on Regenerative Medicine Products Including Stem Cells and ExosomesU.S. Food and Drug Administration
Reported risks of unapproved regenerative productsThe FDA lists blindness, tumor formation, neurological events and bacterial infections, including life-threatening blood infections기준 2024년 4월 8일[3]governmentImportant Patient and Consumer Information About Regenerative Medicine TherapiesU.S. Food and Drug Administration
Growth hormone for aging (US legal status)Distributing human growth hormone off-label to treat aging or age-related illness is illegal under the 1988 and 1990 amendments to the Food, Drug and Cosmetic Act (JAMA analysis, 2005)기준 2005년 11월 8일[4]newsGrowth Hormone Illegal For Off-label Anti-aging Use, Study WarnsScienceDaily (reporting Perls, Reisman & Olshansky, JAMA)
Evidence on growth hormone as anti-aging therapyA systematic review (Liu et al., Annals of Internal Medicine, 2007; 18 study populations, 220 participants) found small changes in fat and lean mass and more adverse events. It concluded that growth hormone cannot be recommended as an anti-aging therapy.기준 2007년 1월 16일[5]academicThe safety and efficacy of growth hormone in the healthy elderly: a systematic reviewHarvard Medical School, Department of Population Medicine (citing Annals of Internal Medicine)
FDA-approved uses of dermal fillersApproved for adults aged 22 and older for moderate-to-severe facial wrinkles and skin folds (e.g., nasolabial folds), for adding fullness to the lips, cheeks, chin and back of the hand, and for facial fat loss in people with HIV기준 2023년 7월 6일[6]governmentDermal Fillers (Soft Tissue Fillers)U.S. Food and Drug Administration
Injectable silicone for aestheticsNot approved by the FDA for any aesthetic procedure. Risks include long-term pain, infection, scarring, permanent disfigurement, embolism, stroke and death.기준 2023년 7월 6일[6]governmentDermal Fillers (Soft Tissue Fillers)U.S. Food and Drug Administration
Most serious dermal filler riskAccidental injection into a blood vessel, which can cause tissue death, blindness or stroke기준 2023년 7월 6일[6]governmentDermal Fillers (Soft Tissue Fillers)U.S. Food and Drug Administration
Korean government view on overseas stem cell programsKorea's Ministry of Health and Welfare found that domestic programs referring patients to stem cell treatment in Japan for money or commissions may violate the Medical Service Act. Cell culture and treatment done abroad fall outside Korean jurisdiction. Experts quoted in the article said the claimed anti-aging effects of stem cell treatment have no scientific basis.기준 2026년 3월 9일[7]news[단독]복지부 "'일본에서 줄기세포 치료' 바이오기업, 불법 소지"Asia Economy (아시아경제)
Regulatory cautionRegulators warn about unproven stem cell products marketed for wellness or anti-aging[1]governmentFDA Warns About Stem Cell TherapiesU.S. Food and Drug Administration

개요

Anti-aging treatment (Korean: 항노화 치료, 안티에이징) is a broad umbrella term, not a single medical specialty, for interventions marketed to reduce visible or physiological signs of ageing. It covers cosmetic procedures (injectable fillers, neuromodulators, laser and energy-based lifting), hormones such as growth hormone or DHEA, supplements, and cell-based products such as stem cells or exosomes. Regulatory status differs by type. The US FDA approves dermal fillers only for specific uses such as facial wrinkles and has approved no exosome products. The only stem cell products it has approved are blood-forming cells from umbilical cord blood. A systematic review concluded that growth hormone cannot be recommended as an anti-aging therapy. Readers should check that a product is approved for the stated use, that the practitioner is licensed, and what published evidence exists.

검증 프로바이더

유료 노출은 표시됩니다. 검증은 결제와 무관합니다.
검증

SC301의원

SC301의원 (SC301 Clinic) is a plastic surgery clinic in Gangnam, Seoul, South Korea whose official site presents SVF (stromal vascular fraction) fat grafting for the breast and face, liposuction, lifting and cell banking as its main services.

프로바이더 보기

근거와 주장

공식 주장은 제공자의 진술이며, 별도 표시가 없는 한 worldwiki가 검증한 것이 아닙니다.
주장유형근거출처
Systemic injection of SVF for anti-aging or wellness is investigational and not an approved treatment in most countries.regulatory높음FDA Warns About Stem Cell Therapies

참고 출처

독립 출처 비율 100% (11/11)
등급 A · 5등급 B · 1등급 C · 3등급 D · 2
  1. 등급 A · governmentFDA Warns About Stem Cell Therapies — U.S. Food and Drug Administration · 확인일 2026년 9월 15일 · 근거 페이지
  2. 등급 A · governmentConsumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes — U.S. Food and Drug Administration · 확인일 2026년 11월 12일 · 근거 페이지
  3. 등급 A · governmentImportant Patient and Consumer Information About Regenerative Medicine Therapies — U.S. Food and Drug Administration · 확인일 2026년 11월 10일 · 근거 페이지
  4. 등급 D · newsGrowth Hormone Illegal For Off-label Anti-aging Use, Study Warns — ScienceDaily (reporting Perls, Reisman & Olshansky, JAMA) · 확인일 2026년 11월 12일 · 근거 페이지
  5. 등급 C · academicThe safety and efficacy of growth hormone in the healthy elderly: a systematic review — Harvard Medical School, Department of Population Medicine (citing Annals of Internal Medicine) · 확인일 2026년 11월 12일 · 근거 페이지
  6. 등급 A · governmentDermal Fillers (Soft Tissue Fillers) — U.S. Food and Drug Administration · 확인일 2026년 11월 12일 · 근거 페이지
  7. 등급 D · news[단독]복지부 "'일본에서 줄기세포 치료' 바이오기업, 불법 소지" — Asia Economy (아시아경제) · 확인일 2026년 11월 12일 · 근거 페이지
  8. 등급 C · organizationAbout Stem Cells — patient resource — International Society for Stem Cell Research · 확인일 2026년 11월 12일 · 근거 페이지
  9. 등급 B · academicSafety profile of autologous adipose-derived stromal vascular fraction in clinical use: an exhaustive literature review — Stem Cell Research & Therapy (2026) · 확인일 2026년 11월 12일 · 근거 페이지
  10. 등급 C · organizationISSCR Guidelines for Stem Cell Research and Clinical Translation — International Society for Stem Cell Research · 확인일 2026년 11월 12일 · 근거 페이지
  11. 등급 A · governmentStem Cell Basics — National Institutes of Health (NIH) · 확인일 2026년 9월 15일 · 근거 페이지
변경 이력
최초 발행 · 2026년 9월 14일